We are live on ! Find out more
SRC

Stone Run Capital Portfolio holdings

AUM $254M
1-Year Est. Return 12.86%
This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+12.86%
3 Year Est. Return
+77.77%
5 Year Est. Return
+98.28%
10 Year Est. Return
+404.21%
AUM
$154M
AUM Growth
-$7.03M
Cap. Flow
-$4.19M
Cap. Flow %
-2.73%
Top 10 Hldgs %
34.74%
Holding
70
New
–
Increased
18
Reduced
15
Closed
4

Top Buys

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$1.49M
2
BDX icon
Becton Dickinson
BDX
+$1.41M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$885K
4
EW icon
Edwards Lifesciences
EW
+$782K
5
MKC icon
McCormick & Company Non-Voting
MKC
+$579K

Top Sells

Rank Stock Value
1
CLB icon
Core Laboratories
CLB
+$2.44M
2
PDCO
Patterson Companies, Inc.
PDCO
+$1.35M
3
ILMN icon
Illumina
ILMN
+$1.33M
4
KEX icon
Kirby Corp
KEX
+$781K
5
WTS icon
Watts Water Technologies
WTS
+$773K

Sector Composition

Rank Sector Weight
1 Healthcare 23.53%
2 Industrials 19.78%
3 Technology 17.3%
4 Materials 14.44%
5 Energy 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DD
51
DELISTED
Du Pont De Nemours E I
DD
$480K 0.31%
6,543
– –
APD icon
52
Air Products & Chemicals
APD
$65.2B
$453K 0.29%
3,150
-255
-7% -$35.7K
AAPL icon
53
Apple
AAPL
$4.46T
$439K 0.29%
15,152
– –
RDS.A
54
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$426K 0.28%
7,837
– –
CNI icon
55
Canadian National Railway
CNI
$76.1B
$371K 0.24%
5,500
– –
MRK icon
56
Merck
MRK
$316B
$349K 0.23%
6,224
– –
OKE icon
57
Oneok
OKE
$55.6B
$342K 0.22%
5,950
– –
ITW icon
58
Illinois Tool Works
ITW
$83B
$325K 0.21%
2,650
– –
MCD icon
59
McDonald's
MCD
$188B
$304K 0.2%
2,500
– –
ABBV icon
60
AbbVie
ABBV
$433B
$270K 0.18%
4,300
– –
D icon
61
Dominion Energy
D
$60.5B
$268K 0.17%
3,500
– –
BEP icon
62
Brookfield Renewable
BEP
$10.2B
$252K 0.16%
15,950
– –
AMGN icon
63
Amgen
AMGN
$204B
$219K 0.14%
1,500
– –
PEP icon
64
PepsiCo
PEP
$191B
$209K 0.14%
2,000
– –
JNJ icon
65
Johnson & Johnson
JNJ
$613B
$202K 0.13%
1,750
– –
PPG icon
66
PPG Industries
PPG
$25.3B
$190K 0.12%
2,000
– –
CLB icon
67
Core Laboratories
CLB
$491M
– –
-21,767
Closed -$2.44M
ILMN icon
68
Illumina
ILMN
$30B
– –
-7,530
Closed -$1.33M
ISRG icon
69
Intuitive Surgical
ISRG
$135B
– –
-2,700
Closed -$217K
PLPM
70
DELISTED
Planet Payment, Inc
PLPM
– –
-12,000
Closed -$45K
1 2
3

Similar funds

TCB
Texas Capital Bancshares Dallas, Texas $254M AUM 27.01% 1-Year Est. Return
OIA
Optimum Investment Advisors Chicago, Illinois $252M AUM 26.44% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WS
Wela Strategies Atlanta, Georgia $264M AUM 16.32% 1-Year Est. Return
MTWM
Masso Torrence Wealth Management Marlton, New Jersey $240M AUM 26.41% 1-Year Est. Return
KSWA
Kathleen S. Wright Associates Pittsburgh, Pennsylvania $270M AUM 12.59% 1-Year Est. Return
GA
Guerra Advisors Miami, Florida $271M AUM 27.78% 1-Year Est. Return
FWM
FSA Wealth Management Needham, Massachusetts $273M AUM 16.98% 1-Year Est. Return

Stone Run Capital's Q4 2016 Portfolio in Review

As of Q4 2016, Stone Run Capital held 70 positions worth $154M, down 4.4% from $161M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Stone Run Capital's Q4 2016 filing shows 18 increased, 15 reduced and 4 closed positions. The largest sale was Core Laboratories, an estimated $2.44M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Industrials and Technology.

  • Stone Run Capital added most to Teleflex in Q4 2016, an estimated $1.49M increase.
  • Stone Run Capital's biggest Q4 2016 reduction was Patterson Companies, Inc., cutting an estimated $1.35M.
  • Stone Run Capital fully exited Core Laboratories in Q4 2016, selling an estimated $2.44M.
  • Stone Run Capital's ten largest holdings make up 35% of its $154M portfolio in Q4 2016.
  • Stone Run Capital opened 0 new positions and closed 4 in Q4 2016.
  • Stone Run Capital's portfolio value fell 4.4% quarter-over-quarter to $154M.

Based on Stone Run Capital's 13F filing for Q4 2016, filed 13 Feb 2017.